Compounds > 3,4-dihydro-5-methyl-1(2h)-isoquinolinone
Page last updated: 2024-09-04

3,4-dihydro-5-methyl-1(2h)-isoquinolinone and 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol

3,4-dihydro-5-methyl-1(2h)-isoquinolinone has been researched along with 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol in 1 studies

Compound Research Comparison

Studies
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)		Trials
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)		Recent Studies (post-2010)
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)		Studies
(1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol)		Trials
(1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol)		Recent Studies (post-2010) (1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol)
160211031

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scavone, SV; Sebolt-Leopold, JS1

Other Studies

1 other study(ies) available for 3,4-dihydro-5-methyl-1(2h)-isoquinolinone and 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol

ArticleYear
Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3

    Topics: Alkylating Agents; Animals; Carmustine; Drug Synergism; In Vitro Techniques; Isoquinolines; Leukemia L1210; Misonidazole; Poly(ADP-ribose) Polymerase Inhibitors; Streptozocin; Tumor Cells, Cultured

1992